Showing results (201-210 of 259) with videos related to

Sort By:
Pageof 26
The Journal of Allergy and Clinical Immunology|February 23, 2018
Mast cells regulate CD4+ T-cell differentiation in the absence of antigen presentationHector Rodriguez Cetina Biefer, Timm Heinbokel, Hirofumi Uehara, et al.
Urologic Oncology|March 29, 2022
Effectiveness of pembrolizumab in patients with urothelial carcinoma receiving proton pump inhibitorsWataru Fukuokaya, Takahiro Kimura, Kazumasa Komura, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|May 2, 2024
Photodynamic diagnosis-assisted transurethral resection of bladder tumor for high-risk non-muscle invasive bladder cancer improves intravesical recurrence-free survival (BRIGHT study)Taketo Kawai, Hideyasu Matsuyama, Keita Kobayashi, et al.
Anticancer Research|January 30, 2026
Prolonged Castration Prior to Docetaxel Reduces Febrile Neutropenia in Patients With Metastatic Hormone-sensitive Prostate Cancer Receiving Triple TherapyYasutaka Yamada, Tomoki Shirafuji, Kodai Sato, et al.
World Journal of Urology|February 18, 2020
Adjuvant chemotherapy improves overall survival in patients with localized upper tract urothelial carcinoma harboring pathologic vascular invasion: a propensity score-matched analysis of multi-institutional cohortTomohisa Matsunaga, Kazumasa Komura, Takeshi Hashimoto, et al.
BMC Cancer|February 28, 2021
Distinct effect of body mass index by sex as a prognostic factor in localized renal cell carcinoma treated with nephrectomy ~ data from a multi-institutional study in Japan ~Takeshi Tsutsumi, Kazumasa Komura, Takeshi Hashimoto, et al.
Anticancer Research|May 27, 2026
Development of a Prognostic Model for Patients Aged ≤65 Years With Metastatic Renal Cell CarcinomaYuya Oishi, Yuto Matsushita, Shinya Watanabe, et al.
Anticancer Research|August 1, 2025
Rash and Endocrine Disorders Predict Improved Survival in Metastatic Renal Cell Carcinoma Treated With ImmunotherapyKoichi Sugimoto, Takafumi Minami, Shingo Toyoda, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|December 19, 2023
Real-world outcomes of avelumab plus axitinib as first-line therapy in patients with advanced renal cell carcinoma in Japan: A multicenter, retrospective, observational study (J-DART)Taigo Kato, Yuzo Nakano, Fumiya Hongo, et al.
Oncogene|September 21, 2021
Increased BUB1B/BUBR1 expression contributes to aberrant DNA repair activity leading to resistance to DNA-damaging agentsKazumasa Komura, Teruo Inamoto, Takuya Tsujino, et al.
Pageof 26